Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue Bone Marrow Transplantation Année : 2020

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers

Sylvain Garciaz
Remy Morello
  • Fonction : Auteur
Krimo Bouabdallah
  • Fonction : Auteur

Dates et versions

hal-02500667 , version 1 (06-03-2020)

Identifiants

Citer

Thomas Hueso, Thomas Gastinne, Sylvain Garciaz, Emmanuelle Tchernonog, Caroline Delette, et al.. Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers. Bone Marrow Transplantation, 2020, 55 (6), pp.1076-1084. ⟨10.1038/s41409-020-0783-y⟩. ⟨hal-02500667⟩
132 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More